extraction technology Cellular Analytics Eyes Drug Development Space with Circulating Tumor Cell Capture Platform Premium Emerging from stealth mode, the Toronto-based firm will use the platform to identify circulating tumor cells and spur drug development in the lung cancer space. Baylor Genetics, Miraca Research Institute Explore EV Purification for Cancer-Based Applications Premium The group will validate Miraca's prototype extracellular vesicle isolation tool and antibody reagents using blood samples from breast and pancreatic patients. Optofluidic Chip Integrates Nanopores, Electrical Feedback to Control Single-Molecule Delivery Premium Researchers have launched a startup called Fluxus to commercialize a platform based on the optofluidic chip for molecular analysis. Caliper Completes Divestiture of Product Lines to Biotage The firm also released pro forma results for its Q1 — reflecting the dispositions of the specialty product lines — showing $2.1 million less in revenues than previously reported, while its cash position increased 45 percent. Qiagen Licenses HandyLab Extraction Technology Qiagen licensed HandyLab's extraction technology for use in the sample prep process for its HPV assays. Mar 3, 2009 LC Sciences Joins Agilent, NimbleGen, Febit, and Others in the Nascent Target Enrichment Market Premium Feb 17, 2009 Febit Plans to Launch HybSelect App in March in Bid to Tap Seq-Capture Market Premium Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.